Want to see CH:SKAN full AI Analyst Report?
SKAN Stock Chart & Stats
CHF65.70
CHF1.00(1.75%)
At close: 4:00 PM EDT
CHF65.70
CHF1.00(1.75%)
Day’s Range― - ―
52-Week RangeCHF35.75 - CHF66.80
Previous CloseN/A
Volume14.18K
Average Volume (3M)35.81K
Market Cap
CHF1.47B
Enterprise ValueCHF1.30K
Total Cash (Recent Filing)CHF88.47M
Total Debt (Recent Filing)CHF130.63M
Price to Earnings (P/E)48.5
Beta1.02
Next Earnings
Mar 23, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.34%
Share Statistics
EPS (TTM)1.33
Shares Outstanding22,483,524
10 Day Avg. Volume54,138
30 Day Avg. Volume35,813
Financial Highlights & Ratios
PEG Ratio-1.26
Price to Book (P/B)10.37
Price to Sales (P/S)3.56
P/FCF Ratio56.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.33
Revenue Forecast (FY)CHF395.52M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthStrong top-line expansion indicates sustained demand for SKAN’s aseptic manufacturing systems, supported by pharmaceutical capacity investment, contamination-control needs, and customer production expansion.
High Gross MarginsConsistently high gross margins suggest differentiated engineered solutions, specialized know-how, and value-added services. This provides a durable earnings cushion even when project execution or operating costs pressure downstream margins.
Improved Cash GenerationThe return to positive free cash flow and stronger operating cash generation improves funding capacity for operations and investment. It also demonstrates that the growing business can generate cash, despite historical project-related volatility.
Bears Say
Sharp Leverage IncreaseThe abrupt increase in leverage, alongside lower equity, materially reduces financial flexibility. Higher debt obligations can constrain investment and amplify the impact of weaker profitability or execution issues across cyclical customer projects.
Profitability DeteriorationThe substantial decline in operating and net margins shows that revenue growth is not yet translating consistently into earnings. Persistent margin pressure could weaken reinvestment capacity and reduce the benefit of SKAN’s strong gross-margin profile.
Volatile Free Cash Flow ConversionUneven free cash flow and limited conversion of reported earnings indicate working-capital or project-timing exposure. This makes internally funded growth less predictable and increases reliance on balance-sheet capacity when investment needs rise.
SKAN Group AG News
SKAN FAQ
What was SKAN Group AG’s price range in the past 12 months?
SKAN Group AG lowest stock price was CHF35.75 and its highest was CHF66.80 in the past 12 months.
What is SKAN Group AG’s market cap?
SKAN Group AG’s market cap is CHF1.47B.
When is SKAN Group AG’s upcoming earnings report date?
SKAN Group AG’s upcoming earnings report date is Mar 23, 2027 which is in 199 days.
How were SKAN Group AG’s earnings last quarter?
SKAN Group AG released its earnings results on Aug 18, 2026. The company reported CHF0.214 earnings per share for the quarter.
Is SKAN Group AG overvalued?
According to Wall Street analysts SKAN Group AG’s price is currently Overvalued.
Does SKAN Group AG pay dividends?
SKAN Group AG pays a Annually dividend of CHF0.22 which represents an annual dividend yield of 0.34%. See more information on SKAN Group AG dividends here
What is SKAN Group AG’s EPS estimate?
SKAN Group AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SKAN Group AG have?
SKAN Group AG has 22,483,524 shares outstanding.
What happened to SKAN Group AG’s price movement after its last earnings report?
SKAN Group AG reported an EPS of CHF0.214 in its last earnings report. Following the earnings report the stock price went up 2.253%.
Which hedge fund is a major shareholder of SKAN Group AG?
Currently, no hedge funds are holding shares in CH:SKAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
SKAN Group AG
SKAN Group AG is a global leader specializing in critical solutions for the pharmaceutical and chemical sectors, offering advanced isolators, cleanroom technologies, and decontamination processes across Asia, Europe, and the Americas. The company operates through two distinct divisions: Equipment and Solutions (E&S), and Services and Consumables (S&C). Its E&S segment delivers essential products for pharmaceutical manufacturing, including high-tech isolators, integrated automated systems, aseptic filling solutions, and specialized laboratory and cleanroom equipment. Meanwhile, the S&C segment focuses on providing comprehensive life cycle support, ready-to-use consumables, and custom digital and client-specific solutions. Founded in 1968, the company, which changed its name from BV Holding AG to SKAN Group AG in October 2021, is headquartered in Allschwil, Switzerland.